The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
9 METERS BIOPHARMA INC | COM | 654405109 | 3,575 | 2,750,000 | SH | SOLE | 2,750,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,950 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 6,146 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 1,826 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 8,999 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 3,855 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,531 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 6,592 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,944 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
ARVINAS INC | COM | 04335A105 | 12,327 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 19,127 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 5,259 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 2,456 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
BEYONDSPRING INC | SHS | G10830100 | 6,304 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 4,159 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BIONTECH SE | SPONSORED ADS | 09075V102 | 546 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 1,216 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CASI PHARMACEUTICALS INC | COM | 14757U109 | 774 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 4,110 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 13,767 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 1,238 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CODEX DNA INC | COM | 192003101 | 390 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 12,615 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 2,987 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 3,158 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 4,720 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 2,964 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,411 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 8,824 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 2,875 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,943 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 2,345 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 1,738 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 17,262 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 21,875 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
IVERIC BIO INC | COM | 46583P102 | 11,774 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 7,960 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 2,306 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 6,617 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 1,650 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 10,615 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MODERNA INC | COM | 60770K107 | 2,040 | 5,300 | SH | SOLE | 5,300 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 864 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 4,623 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PROVENTION BIO INC | COM | 74374N102 | 320 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 7,763 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 5,242 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 10,462 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 4,214 | 904,225 | SH | SOLE | 904,225 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 4,384 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 10,988 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 3,664 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
TCR2 THERAPEUTICS INC | COM | 87808K106 | 4,062 | 477,323 | SH | SOLE | 477,323 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 4,059 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 4,110 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,758 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 5,480 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 12,071 | 790,000 | SH | SOLE | 790,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,820 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 4,332 | 65,000 | SH | SOLE | 65,000 | 0 | 0 |